Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.
Gastroenterology
; 152(1): 53-67.e3, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27773806
Technologies such as genome sequencing, gene expression profiling, proteomic and metabolomic analyses, electronic medical records, and patient-reported health information have produced large amounts of data from various populations, cell types, and disorders (big data). However, these data must be integrated and analyzed if they are to produce models or concepts about physiological function or mechanisms of pathogenesis. Many of these data are available to the public, allowing researchers anywhere to search for markers of specific biological processes or therapeutic targets for specific diseases or patient types. We review recent advances in the fields of computational and systems biology and highlight opportunities for researchers to use big data sets in the fields of gastroenterology and hepatology to complement traditional means of diagnostic and therapeutic discovery.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Computational Biology
/
Drug Discovery
/
Gastrointestinal Diseases
/
Liver Diseases
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Gastroenterology
Year:
2017
Type:
Article